Gilead gets 2nd HIV drug approved for PrEP

The FDA approved Gilead Sciences ' Descovy for PrEP among male adults and adolescents who are HIV-negative and considered to be at risk.

Source: PharmaManufacturing.com - October 7, 2019 Category: Pharmaceuticals Source Type: news